Citation: Wa. Briggs et al., SUCCESSFUL MYCOPHENOLATE MOFETIL TREATMENT OF GLOMERULAR-DISEASE, American journal of kidney diseases, 31(2), 1998, pp. 213-217
Authors:
BRIGGS WA
EUSTACE J
MATHEW S
GIMENEZ LF
CHOI M
SCHEEL PJ
BURDICK J
Citation: Wa. Briggs et al., PENTOXIFYLLINE POTENTIATES IN-VITRO LYMPHOCYTE SUPPRESSION BY GLUCOCORTICOIDS AND IMMUNOSUPPRESSIVE DRUGS, Journal of clinical pharmacology, 38(6), 1998, pp. 561-566
Citation: Gs. Phillips et al., UNILATERAL BREAST ENLARGEMENT - 4 CASE-REPORTS OF AN UNUSUAL PRESENTATION OF CENTRAL VEIN STENOSIS IN PATIENTS UNDERGOING HEMODIALYSIS, Surgery, 123(6), 1998, pp. 699-701
Authors:
SAVADER SJ
LUND G
SCHEEL PJ
PRESCOTT C
FEELEY N
SINGH H
OSTERMAN FA
Citation: Sj. Savader et al., GUIDE-WIRE DIRECTED MANIPULATION OF MALFUNCTIONING PERITONEAL-DIALYSIS CATHETERS - A CRITICAL ANALYSIS, Journal of vascular and interventional radiology, 8(6), 1997, pp. 957-963
Authors:
BRIGGS WA
CHOI M
SCHEEL PJ
ONUCHIC LF
MATHEW S
Citation: Wa. Briggs et al., MYCOPHENOLATE MOFETIL TREATMENT OF GLOMERULAR-DISEASE, Journal of the American Society of Nephrology, 8, 1997, pp. 396-396
Authors:
BRIGGS WA
EUSTACE J
MATHEW S
GIMENEZ L
CHOI M
SCHEEL PJ
BURDICK J
Citation: Wa. Briggs et al., PENTOXIPHYLLINE POTENTIATES THE SUPPRESSION OF LYMPHOCYTE-PROLIFERATION BY STEROIDS, CYCLOSPORINE AND RAPAMYCIN, Journal of the American Society of Nephrology, 8, 1997, pp. 3049-3049
Citation: Wa. Briggs et al., SUPPRESSION OF DIALYSIS PATIENTS LYMPHOCYTE IL-2R EXPRESSION BY GLUCOCORTICOIDS AND CYCLOSPORINE, Cytokine, 9(8), 1997, pp. 624-628
Authors:
TREROTOLA SO
SCHEEL PJ
POWE NR
PRESCOTT C
FEELEY N
HE J
WATSON A
Citation: So. Trerotola et al., SCREENING FOR DIALYSIS ACCESS GRAFT MALFUNCTION - COMPARISON OF PHYSICAL-EXAMINATION WITH US, Journal of vascular and interventional radiology, 7(1), 1996, pp. 15-20
Citation: Wa. Briggs et al., DIFFERENTIAL SUPPRESSION OF DIALYSIS PATIENTS LYMPHOCYTE IFN-GAMMA PRODUCTION BY GLUCOCORTICOIDS AND CYCLOSPORINE, Cytokine, 8(10), 1996, pp. 804-808
Authors:
BRIGGS WA
TANAWATTANACHAROEN S
CHOI MJ
SCHEEL PJ
NADASDY T
RACUSEN L
Citation: Wa. Briggs et al., CLINICOPATHOLOGICAL CORRELATES OF PREDNISONE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NEPHROPATHY, American journal of kidney diseases, 28(4), 1996, pp. 618-621
Citation: Wa. Briggs et al., LYMPHOCYTE RESPONSIVENESS TO GLUCOCORTICOIDS, CYCLOSPORINE, OR BOTH, Journal of clinical pharmacology, 36(8), 1996, pp. 707-714
Citation: Wa. Briggs et al., SUPPRESSION OF LYMPHOCYTE INTERLEUKIN-2 RECEPTOR EXPRESSION BY GLUCOCORTICOIDS, CYCLOSPORINE, OR BOTH, Journal of clinical pharmacology, 36(10), 1996, pp. 931-937
Citation: Wa. Briggs et al., HETEROGENEITY OF DIALYSIS PATIENT LYMPHOCYTE-RESPONSES TO CYCLOSPORINE, Transplantation proceedings, 28(4), 1996, pp. 2063-2065
Authors:
VASSALOTTI JA
CHOI M
WHELTON A
BRIGGS W
GIMENEZ L
SCHEEL PJ
Citation: Ja. Vassalotti et al., ACCESS-RELATED INFECTION IN HIV-SEROPOSITIVE DIALYSIS PATIENTS - COMPARISON OF HEMODIALYSIS TO PERITONEAL-DIALYSIS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 514-514
Authors:
SCHEEL PJ
FARZADEGAN H
FORD D
MALAN M
WATSON A
Citation: Pj. Scheel et al., RECOVERY OF HUMAN-IMMUNODEFICIENCY-VIRUS FROM PERITONEAL-DIALYSIS EFFLUENT, Journal of the American Society of Nephrology, 5(11), 1995, pp. 1926-1929
Citation: Gb. Lund et al., PERCUTANEOUS TRANSLUMBAR INFERIOR VENA-CAVA CANNULATION FOR HEMODIALYSIS, American journal of kidney diseases, 25(5), 1995, pp. 732-737
Citation: Lf. Gimenez et Pj. Scheel, CLINICAL-APPLICATION OF RECOMBINANT ERYTHROPOIETIN IN RENAL DIALYSIS PATIENTS, Hematology/oncology clinics of North America, 8(5), 1994, pp. 913